<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Cancer Detection | Seppälä Lab</title><link>https://www.seppalalab.org/tag/cancer-detection/</link><atom:link href="https://www.seppalalab.org/tag/cancer-detection/index.xml" rel="self" type="application/rss+xml"/><description>Cancer Detection</description><generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en</language><lastBuildDate>Thu, 15 May 2025 00:00:00 +0000</lastBuildDate><image><url>https://www.seppalalab.org/media/logo_hu_e3f0d28ad302f75b.png</url><title>Cancer Detection</title><link>https://www.seppalalab.org/tag/cancer-detection/</link></image><item><title>EUR 13.6 Million Funding for Early Detection of Lynch Syndrome Cancers</title><link>https://www.seppalalab.org/post/2026-lynch-syndrome-funding/</link><pubDate>Thu, 15 May 2025 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/post/2026-lynch-syndrome-funding/</guid><description>&lt;p&gt;Seppälä Lab has received EUR 13.6 million in funding to advance early detection of Lynch syndrome-associated cancers. Lynch syndrome is one of the most common hereditary cancer predisposition syndromes, significantly increasing lifetime risk of colorectal, endometrial, and other cancers.&lt;/p&gt;
&lt;p&gt;This funding will support development of novel screening approaches and biomarkers aimed at earlier, more accurate detection — improving outcomes for Lynch syndrome carriers and their families.&lt;/p&gt;
&lt;p&gt;&lt;a href="https://www.tuni.fi/en/tau/news-and-events/eur13-6-million-funding-early-detection-lynch-syndrome-cancers" target="_blank" rel="noopener"&gt;Read the full news article at Tampere University →&lt;/a&gt;&lt;/p&gt;</description></item></channel></rss>